|
RGC replacement one step closer to reality
|
|
Progress on several fronts is creating optimism that retinal ganglion cell (RGC) replacement may become a reality for preserving or restoring vision in patients with glaucoma. Jeffrey L. Goldberg, MD, PhD, explains.
|
|
Continue
|
|
|
|
How Medicare Part D affects your glaucoma patients
|
|
Two new glaucoma drugs approved in late 2017 are not on the 2018 Medicare Part D formulary, creating quandaries for physicians who would like to prescribe them and for patients who may have to pay out of pocket. Here’s what you and your patients should know.
|
|
Learn more
|
